Spirosure

Spirometrix is an emerging company located in Pleasanton, California, dedicated to the research, development, and commercialization of novel respiratory analysis devices for disease diagnosis and management. Spirosure, founded in 2011 by Dr. Solomon Ssenyange and Ryan Leard, focuses on innovative testing technologies applied to asthma diagnosis and disease management. In recent years, fractional exhaled nitric oxide (FeNO) has become a crucial biomarker for asthma detection, and the Fenom Pro™ product is a testing solution based on such innovative technology applications.The company’s mission is to provide consumers with cost-effective, non-invasive products for managing chronic conditions such as asthma, COPD, and chronic pulmonary hypertension through a proprietary portfolio of sensors and sensor-based products, utilizing a range of consumer technologies for healthcare prevention and algorithm development.